181 related articles for article (PubMed ID: 3259623)
21. Effect of selecting a fixed dephosphorylation rate on the estimation of rate constants and rCMRGlu from dynamic [18F] fluorodeoxyglucose/PET data.
Dhawan V; Moeller JR; Strother SC; Evans AC; Rottenberg DA
J Nucl Med; 1989 Sep; 30(9):1483-8. PubMed ID: 2788721
[TBL] [Abstract][Full Text] [Related]
22. [Cerebral glucose metabolism in autistic children. Study and positron emission tomography].
De Volder AG; Bol A; Michel C; Cogneau M; Goffinet AM
Acta Neurol Belg; 1988; 88(2):75-90. PubMed ID: 3260437
[TBL] [Abstract][Full Text] [Related]
23. Cerebral glucose metabolism during pharmacologic studies: test-retest under placebo conditions.
Schmidt ME; Ernst M; Matochik JA; Maisog JM; Pan BS; Zametkin AJ; Potter WZ
J Nucl Med; 1996 Jul; 37(7):1142-9. PubMed ID: 8965185
[TBL] [Abstract][Full Text] [Related]
24. Effects of percent thresholding on the extraction of [18F]fluorodeoxyglucose positron emission tomographic region-of-interest data.
Rottenberg DA; Moeller JR; Strother SC; Dhawan V; Sergi ML
J Cereb Blood Flow Metab; 1991 Mar; 11(2):A83-8. PubMed ID: 1997493
[TBL] [Abstract][Full Text] [Related]
25. PET studies of cerebral glucose metabolism in conscious rhesus macaques.
Eberling JL; Roberts JA; De Manincor DJ; Brennan KM; Hanrahan SM; Vanbrocklin HF; Roos MS; Jagust WJ
Neurobiol Aging; 1995; 16(5):825-32. PubMed ID: 8532117
[TBL] [Abstract][Full Text] [Related]
26. [No hypofrontality in schizophrenia demonstrated by positron emission tomography].
Biver F; Delvenne V; Goldman S; Luxen A; De Maertelaer V; Lotstra F; Mendlewicz J
Acta Psychiatr Belg; 1992; 92(5):261-78. PubMed ID: 1345405
[TBL] [Abstract][Full Text] [Related]
27. [Hemocirculation and metabolism in intraventricular tumors: kinetic analysis of glucose metabolism].
Shioya H; Mineura K; Kowada M; Iida H; Murakami M; Ogawa T; Hatazawa J; Uemura K
No Shinkei Geka; 1996 Mar; 24(3):211-9. PubMed ID: 8851949
[TBL] [Abstract][Full Text] [Related]
28. Effect of barbiturate coma on glucose utilization in normal brain versus gliomas. Positron emission tomography studies.
Blacklock JB; Oldfield EH; Di Chiro G; Tran D; Theodore W; Wright DC; Larson SM
J Neurosurg; 1987 Jul; 67(1):71-5. PubMed ID: 3496428
[TBL] [Abstract][Full Text] [Related]
29. Disturbance of oxidative metabolism of glucose in recent human cerebral infarcts.
Wise RJ; Rhodes CG; Gibbs JM; Hatazawa J; Palmer T; Frackowiak RS; Jones T
Ann Neurol; 1983 Dec; 14(6):627-37. PubMed ID: 6606390
[TBL] [Abstract][Full Text] [Related]
30. [Cerebral glucose metabolism in dementia (PET-FDG study)].
Hatazawa J; Itoh M; Matsuzawa T
Rinsho Hoshasen; 1989 Oct; 34(11):1343-8. PubMed ID: 2601096
[TBL] [Abstract][Full Text] [Related]
31. Interregional correlation of cerebral glucose metabolism in unmedicated schizophrenia.
Biver F; Goldman S; De Maertelaer V; Luxen A; Mendlewicz J; Lotstra F
Eur Neuropsychopharmacol; 1996 May; 6(2):141-7. PubMed ID: 8791040
[TBL] [Abstract][Full Text] [Related]
32. Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate.
Kuwabara H; Gjedde A
J Nucl Med; 1991 Apr; 32(4):692-8. PubMed ID: 2013809
[TBL] [Abstract][Full Text] [Related]
33. Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age.
Loessner A; Alavi A; Lewandrowski KU; Mozley D; Souder E; Gur RE
J Nucl Med; 1995 Jul; 36(7):1141-9. PubMed ID: 7790936
[TBL] [Abstract][Full Text] [Related]
34. Regional cerebral glucose metabolism during sevoflurane anaesthesia in healthy subjects studied with positron emission tomography.
Schlünzen L; Juul N; Hansen KV; Gjedde A; Cold GE
Acta Anaesthesiol Scand; 2010 May; 54(5):603-9. PubMed ID: 20085540
[TBL] [Abstract][Full Text] [Related]
35. Regional cerebral oxidative and total glucose consumption during rest and activation studied with positron emission tomography.
Blomqvist G; Seitz RJ; Sjögren I; Halldin C; Stone-Elander S; Widén L; Solin O; Haaparanta M
Acta Physiol Scand; 1994 May; 151(1):29-43. PubMed ID: 8048334
[TBL] [Abstract][Full Text] [Related]
36. Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study.
Otte A; Weiner SM; Peter HH; Mueller-Brand J; Goetze M; Moser E; Gutfleisch J; Hoegerle S; Juengling FD; Nitzsche EU
Eur J Nucl Med; 1997 Jul; 24(7):787-91. PubMed ID: 9211766
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
[TBL] [Abstract][Full Text] [Related]
38. The cerebral metabolic landscape in autism. Intercorrelations of regional glucose utilization.
Horwitz B; Rumsey JM; Grady CL; Rapoport SI
Arch Neurol; 1988 Jul; 45(7):749-55. PubMed ID: 3260481
[TBL] [Abstract][Full Text] [Related]
39. Decreased brain metabolism in neurologically intact healthy alcoholics.
Volkow ND; Hitzemann R; Wang GJ; Fowler JS; Burr G; Pascani K; Dewey SL; Wolf AP
Am J Psychiatry; 1992 Aug; 149(8):1016-22. PubMed ID: 1636801
[TBL] [Abstract][Full Text] [Related]
40. Reproducibility of regional brain metabolic responses to lorazepam.
Wang GJ; Volkow ND; Overall J; Hitzemann RJ; Pappas N; Pascani K; Fowler JS
J Nucl Med; 1996 Oct; 37(10):1609-13. PubMed ID: 8862292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
